Myocardial fibrosis imaging in patients with hypertension

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100053113

Enrollment

Unknown

Registered

2021-11-12

Start date

2021-11-08

Completion date

Unknown

Last updated

2022-09-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Interventions

case series:Nil

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.Clinically diagnosed patients with hypertension; 2.Able to complete the inspection.

Exclusion criteria

Exclusion criteria: 1.Other cardiac or systemic diseases that can cause cardiac hypertrophy, such as aortic stenosis, hypertrophic cardiomyopathy, amyloidosis, etc.; 2.History of coronary heart disease and myocardial infarction; 3.Cardiomyopathy; 4.History of malignant tumor; 5.Other obvious systemic diseases; 6.Systemic inflammation or infectious diseases.

Design outcomes

Primary

Measure	Time frame
Myocardial radionuclide imaging activity;Routine blood index examination;	—

Countries

China

Contacts

Public ContactXie Boqia

Cardiac Center, Beijing Chaoyang Hospital, Capital Medical University

xiaoqiaqiaisme@163.com+86 13552411256

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026